Related references
Note: Only part of the references are listed.Interferon-based treatment of chronic hepatitis D
Lisa Sandmann et al.
LIVER INTERNATIONAL (2023)
Itemization difference of patient-reported outcome in patients with chronic liver disease
Ming-Chieh Lin et al.
PLOS ONE (2022)
Bulevirtide with or without pegIFNa for patients with compensated chronic hepatitis delta: From clinical trials to real-world studies
Pietro Lampertico et al.
JOURNAL OF HEPATOLOGY (2022)
Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting-results from the German Hepatitis C-Registry (DHC-R)
Valerie Ohlendorf et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Stephan Urban et al.
GUT (2021)
Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
Maria Buti et al.
JHEP REPORTS (2021)
Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
Dulce Alfaiate et al.
JOURNAL OF HEPATOLOGY (2020)
Long-Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver-Related Outcomes
Habiba Kamal et al.
HEPATOLOGY (2020)
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis
Alexander J. Stockdale et al.
JOURNAL OF HEPATOLOGY (2020)
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta
Dominique Roulot et al.
JOURNAL OF HEPATOLOGY (2020)
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Heiner Wedemeyer et al.
LANCET INFECTIOUS DISEASES (2019)
Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease
Cihan Yurdaydin et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Antiviral Treatment and Liver- Related Complications in Hepatitis Delta
Anika Wranke et al.
HEPATOLOGY (2017)
Hepatitis delta-associated mortality in HIV/HBV-coinfected patients
Charles Beguelin et al.
JOURNAL OF HEPATOLOGY (2017)
Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity
Katja Deterding et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Henry L. Y. Chan et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients
Jose Vicente Fernandez-Montero et al.
CLINICAL INFECTIOUS DISEASES (2014)
Development and evaluation of a baseline-event-anticipation score for hepatitis delta
B. Calle Serrano et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study
Vibeke Strand et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2013)
Quality of life in patients with various liver diseases
H. L. Tillmann et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
Heiner Wedemeyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn's disease
G. Coteur et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Pegylated Interferon and Ribavirin-Induced Depression in Chronic Hepatitis C: Role of Personality
Pere Castellvi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Host-rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection
B. Helbling et al.
GUT (2008)
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis
Herbert L. Bonkovsky et al.
JOURNAL OF HEPATOLOGY (2007)
Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin
MR Kraus et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)